| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AILERON THERAPEUTICS INC | President and COO | Common Stock | 7.12K | $24K | $3.37 | Mar 5, 2024 | Direct |
| AILERON THERAPEUTICS INC | President and COO | Common Stock | 225 | $758 | $3.37 | Mar 5, 2024 | By son |
| AILERON THERAPEUTICS INC | President and COO | Series X Non-Voting Convertible Preferred | 0 | Mar 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALRN | AILERON THERAPEUTICS INC | Mar 5, 2024 | 2 | $0 | 4 | Mar 6, 2024 | President and COO |
| ALRN | AILERON THERAPEUTICS INC | Dec 15, 2023 | 1 | $758 | 4 | Dec 18, 2023 | President and COO |
| ALRN | AILERON THERAPEUTICS INC | Nov 20, 2023 | 1 | $9.99K | 4 | Nov 21, 2023 | President and COO |
| ALRN | AILERON THERAPEUTICS INC | Oct 31, 2023 | 0 | $0 | 3 | Nov 2, 2023 | Exhibit 24.1 Power of Attorney President and Chief Operating Officer |